7.60

0.65% -0.05

Bioventus Inc (BVS)

Overview News Price History Option Chain Financials Discussions Forecast

Bioventus Inc stock is traded at $7.60, with a volume of 81,176. It is down -0.65% in the last 24 hours and up +7.19% over the past month. Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Previous Close:

$7.65

Open:

$7.67

24h Volume:

81,176

Relative Volume:

0.28

Market Cap:

$509.69M

Revenue:

$555.06M

Net Income/Loss:

$-39.48M

P/E Ratio:

-12.67

EPS:

-0.6

Net Cash Flow:

$29.05M

1W Performance:

+2.15%

1M Performance:

+7.19%

6M Performance:

+11.44%

1Y Performance:

-20.42%

1-Day Range:

$7.48

$7.70

1-Week Range:

$7.14

$7.78

52-Week Range:

$5.81

$11.25

Bioventus Inc Stock (BVS) Company Profile

Name

Bioventus Inc

Sector

Healthcare (1120)

Industry

Medical Devices (141)

Phone

(919) 474-6700

Address

4721 EMPEROR BOULEVARD, SUITE 100, DURHAM

Employee

950

Twitter

Next Earnings Date

2025-03-11

Latest SEC Filings

BVS's Discussions on Twitter

Compare BVS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BVS Bioventus Inc	7.61	512.37M	555.06M	-39.48M	29.05M	-0.60
ABT Abbott Laboratories	127.03	222.19B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	98.64	144.97B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	367.64	140.12B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	99.78	128.60B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	84.58	49.82B	5.88B	1.34B	799.60M	2.3489

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-07-25	Initiated	Cantor Fitzgerald	Overweight
Dec-17-24	Upgrade	JP Morgan	Underweight → Neutral
Dec-07-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-09-23	Upgrade	Craig Hallum	Hold → Buy
Nov-22-22	Downgrade	Craig Hallum	Buy → Hold
Nov-09-22	Downgrade	Canaccord Genuity	Buy → Hold
Nov-09-22	Downgrade	JP Morgan	Overweight → Underweight
Mar-15-22	Initiated	Craig Hallum	Buy
Nov-15-21	Resumed	Morgan Stanley	Overweight
Nov-10-21	Resumed	JP Morgan	Overweight
Jul-01-21	Downgrade	Goldman	Buy → Neutral
Mar-08-21	Initiated	Canaccord Genuity	Buy
Mar-08-21	Initiated	Goldman	Buy
Mar-08-21	Initiated	JP Morgan	Overweight
Mar-08-21	Initiated	Morgan Stanley	Overweight

View All

Bioventus Inc Stock (BVS) Latest News

Jan 06, 2026

Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 06, 2026

Jan 04, 2026

(BVS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Jan 04, 2026

Jan 02, 2026

BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN

Jan 02, 2026

Jan 01, 2026

Will Bioventus Inc stock deliver consistent dividends2025 Earnings Impact & Growth Focused Investment Plans - moha.gov.vn

Jan 01, 2026

Dec 31, 2025

Bioventus (NYSE:BVS) Trading Down 1.1%Time to Sell? - MarketBeat

Dec 31, 2025

Dec 24, 2025

Why (BVS) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Dec 24, 2025

Dec 20, 2025

Aug Analyst Calls: Why Bioventus Inc stock could outperform in 2025Gap Up & Weekly Breakout Opportunity Watchlist - moha.gov.vn

Dec 20, 2025

Will Bioventus Inc. stock deliver consistent dividends2025 Market Outlook & Verified High Yield Trade Plans - Bölüm Sonu Canavarı

Dec 20, 2025

Why Bioventus Inc. stock is favored by top institutionsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда

Dec 20, 2025

What Wall Street predicts for Bioventus Inc. stock priceJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - Улправда

Dec 20, 2025

Dec 19, 2025

Will Bioventus Inc. stock benefit from automationJuly 2025 Institutional & Reliable Price Breakout Alerts - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Will Bioventus Inc. stock rally after Fed decisionsJuly 2025 Opening Moves & Target Return Focused Stock Picks - Улправда

Dec 18, 2025

Is Bioventus Inc. stock resilient to inflation2025 Market WrapUp & Community Consensus Picks - Улправда

Dec 18, 2025

BVS (Bioventus) Purchase Of Investment : $0.0 Mil (TTM As of Sep. 2025) - GuruFocus

Dec 18, 2025

Bioventus Director Guy P Nohra Sells 10,000 Shares - TradingView — Track All Markets

Dec 08, 2025

Dir Nohra Sells 10,000 ($75.7K) Of Bioventus Inc [BVS] - TradingView — Track All Markets

Dec 08, 2025

Divisadero Street Capital Management LP Decreases Stock Position in Bioventus Inc. $BVS - MarketBeat

Dec 08, 2025

Dec 06, 2025

Geode Capital Management LLC Has $6.98 Million Stake in Bioventus Inc. $BVS - Defense World

Dec 06, 2025

American Century Companies Inc. Grows Stock Holdings in Bioventus Inc. $BVS - Defense World

Dec 06, 2025

Dec 05, 2025

Buy Signal: Why Bioventus Inc stock is favored by top institutionsQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - moha.gov.vn

Dec 05, 2025

HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire

Dec 05, 2025

Dec 04, 2025